Empresaria Group (EMR)

Sector:

Support

Index:

FTSE AIM All-Share

38.33p
   
  • Change Today:
      0.33p
  • 52 Week High: 62.50
  • 52 Week Low: 31.50
  • Currency: UK Pounds
  • Shares Issued: 49.85m
  • Volume: 7,500
  • Market Cap: £19.11m
  • RiskGrade: 45

Emprasaria acquires remainder of Ball and Hoolahan

By Josh White

Date: Friday 29 Apr 2016

LONDON (ShareCast) - (ShareCast News) - Empresaria celebrated the completion of a major purchase on Friday, acquiring the remaining 25% of Ball and Hoolahan (B&H) from Roy Hoolahan, as part of a planned succession.
The AIM-traded firm acquired a 75% interest in B&H on 15 December 2014. Empresaria confirmed it paid consideration of £0.2m for the minority interest on Friday.

Empresaria's board described B&H as an established UK-based recruiter serving the marketing industry.

Marc Sigrist, who joined B&H as operations director in December, will now replace Hoolahan as managing director. Hoolahan will stay on as a strategic consultant.

In the 12 months to 31 December, B&H generated revenue of £2.2m, and profit before tax of £0.3m, Empresaria confirmed.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

EMR Market Data

Currency UK Pounds
Share Price 38.33p
Change Today 0.33p
% Change 0.88 %
52 Week High 62.50
52 Week Low 31.50
Volume 7,500
Shares Issued 49.85m
Market Cap £19.11m
RiskGrade 45

EMR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.90% above the market average23.90% above the market average23.90% above the market average23.90% above the market average23.90% above the market average
28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average28.89% above the sector average
Price Trend
60.14% below the market average60.14% below the market average60.14% below the market average60.14% below the market average60.14% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Income
78.89% below the market average78.89% below the market average78.89% below the market average78.89% below the market average78.89% below the market average
77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average77.78% below the sector average
Growth
98.29% below the market average98.29% below the market average98.29% below the market average98.29% below the market average98.29% below the market average
97.98% below the sector average97.98% below the sector average97.98% below the sector average97.98% below the sector average97.98% below the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

EMR Dividends

  Latest Previous
  Final Final
Ex-Div 23-May-24 25-May-23
Paid 13-Jun-24 15-Jun-23
Amount 1.00p 1.40p

Trades for 07-May-2024

Time Volume / Share Price
14:48 7,500 @ 38.49p

EMR Key Personnel

CFO Tim Anderson
CEO Rhona Driggs

Top of Page